The data is reviewed by a panel of clinical specialists. My information is that they convene more-or-less monthly, and the next review meeting is set for mid-August.
The document you mention is just the first step towards approval. It is merely a "receipt of application" thing. More of a courtesy than anything else.
- Forums
- ASX - By Stock
- SLA
- after hours
after hours, page-7
-
- There are more pages in this discussion • 14 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)